Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124865153 | 12486515 | 3 | F | 20160808 | 20160621 | 20160815 | PER | US-ELI_LILLY_AND_COMPANY-US201606000433 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160815 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124865153 | 12486515 | 1 | PS | HUMULIN N | INSULIN HUMAN | 1 | Unknown | UNK UNK, UNKNOWN | U | U | 18780 | ||||||||
| 124865153 | 12486515 | 2 | SS | HUMULIN N | INSULIN HUMAN | 1 | U | U | 18780 | ||||||||||
| 124865153 | 12486515 | 3 | C | ALBUTEROL /00139502/ | ALBUTEROL | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 4 | C | AMFETAMINE SULFATE W/DEXAMFETAMINE | 2 | U | 0 | ||||||||||||
| 124865153 | 12486515 | 5 | C | CELECOXIB. | CELECOXIB | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 6 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 7 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 8 | C | CYCLOSPORINE. | CYCLOSPORINE | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 11 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 12 | C | LIRAGLUTIDE | LIRAGLUTIDE | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 13 | C | LOSARTAN. | LOSARTAN | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 14 | C | MAGNESIUM /07349401/ | 2 | U | 0 | ||||||||||||
| 124865153 | 12486515 | 15 | C | OMEPRAZOL /00661201/ | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 124865153 | 12486515 | 16 | C | OXYCODON | OXYCODONE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124865153 | 12486515 | 1 | Gestational diabetes |
| 124865153 | 12486515 | 2 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124865153 | 12486515 | Maternal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |